Implications of flavonoids as potential modulators of cancer neovascularity

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Angiogenesis, the formation of new blood vessels, is crucial for tissue repair and cancer progression.
• Anti-angiogenic therapies offer potential for cancer treatment but face challenges like drug resistance.
• Personalized medicine approaches, including predictive markers, can improve cancer treatment efficacy.

Purpose of the Study:

• To review the anticancer potential of flavonoids, focusing on their anti-angiogenic effects.
• To evaluate current preclinical and clinical research on flavonoid-mediated anti-angiogenesis in cancer.

Main Methods:

• Comprehensive literature review of preclinical and clinical studies.
• Analysis of flavonoid efficacy in modulating tumor angiogenesis.
• Examination of signaling pathways involved in flavonoid anti-angiogenic action.

Main Results:

• Flavonoids, abundant dietary phytochemicals, demonstrate significant anticancer effects.
• Flavonoids effectively regulate tumor angiogenesis by modulating key signaling molecules (e.g., VEGF, MMPs, ILs, HIF).
• Preclinical research extensively supports the anti-angiogenic role of flavonoids in cancer.

Conclusions:

• Flavonoids possess considerable anticancer potential attributed to their anti-angiogenic properties.
• While preclinical data are robust, clinical studies on flavonoid anti-angiogenic effects require further investigation.
• Understanding flavonoid mechanisms could enhance personalized cancer treatment strategies.